Open Access
Open access
Frontiers in Neuroscience, volume 14

New PAR1 Agonist Peptide Demonstrates Protective Action in a Mouse Model of Photothrombosis-Induced Brain Ischemia

Publication typeJournal Article
Publication date2020-05-19
Quartile SCImago
Q2
Quartile WOS
Q2
Impact factor4.3
ISSN16624548, 1662453X
General Neuroscience
Abstract
Protease-activated receptors (PARs) are involved not only in hemostasis, but also in the development of ischemic brain injury. In the present work, we examined in vivo effects of a new peptide (AP9) composing Asn47-Phen55 of PAR1 "tethered ligand" generated by activated protein C. We chose a mouse model of photothrombosis-induced (PT-induced) ischemia to assess AP9 effects in vivo. To reveal the molecular mechanism of AP9 action, mice lacking β-arrestin-2 were used. AP9 was injected intravenously once 10 min before PT at doses of 0.2, 2, or 20 mg/kg, or twice, i.e. 10 min before and 1 h after PT at a dose of 20 mg/kg. Lesion volume was measured by magnetic resonance imaging and staining of brain sections with tetrazolium salt. A neurologic deficit was estimated using the cylinder and the grid-walk tests. Blood-brain barrier disruption was assessed by Evans blue dye extraction. Eosin and hematoxylin and immunohistochemical staining were applied to evaluate the number of undamaged neurons and activated glial cells in the penumbra. A single administration of AP9 (20 mg/kg), as well as its two injections (20 mg/kg) decreased brain lesion volume. A double administration of AP9 also reduced blood-brain barrier disruption and neurological deficit in mice. We did not observe the protective effect of AP9 in mice lacking β-arrestin-2 after PT. Thus, we demonstrated for the first time protective properties of PAR1 agonist peptide, AP9, in vivo. β-Arrestin-2 was required for the protective action of AP9 in PT-induced brain ischemia.

Citations by journals

1
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 100%
International Journal of Molecular Sciences
1 publication, 100%
1

Citations by publishers

1
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 1, 100%
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 100%
1
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Galkov M. et al. New PAR1 Agonist Peptide Demonstrates Protective Action in a Mouse Model of Photothrombosis-Induced Brain Ischemia // Frontiers in Neuroscience. 2020. Vol. 14.
GOST all authors (up to 50) Copy
Galkov M., Kiseleva E., Gulyaev M., Sidorova M., Gorbacheva L. New PAR1 Agonist Peptide Demonstrates Protective Action in a Mouse Model of Photothrombosis-Induced Brain Ischemia // Frontiers in Neuroscience. 2020. Vol. 14.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3389/fnins.2020.00335
UR - https://doi.org/10.3389%2Ffnins.2020.00335
TI - New PAR1 Agonist Peptide Demonstrates Protective Action in a Mouse Model of Photothrombosis-Induced Brain Ischemia
T2 - Frontiers in Neuroscience
AU - Galkov, Maksim
AU - Kiseleva, Ekaterina
AU - Gulyaev, Mikhail
AU - Sidorova, Maria
AU - Gorbacheva, Liubov
PY - 2020
DA - 2020/05/19 00:00:00
PB - Frontiers Media S.A.
VL - 14
PMID - 32547356
SN - 1662-4548
SN - 1662-453X
ER -
BibTex
Cite this
BibTex Copy
@article{2020_Galkov,
author = {Maksim Galkov and Ekaterina Kiseleva and Mikhail Gulyaev and Maria Sidorova and Liubov Gorbacheva},
title = {New PAR1 Agonist Peptide Demonstrates Protective Action in a Mouse Model of Photothrombosis-Induced Brain Ischemia},
journal = {Frontiers in Neuroscience},
year = {2020},
volume = {14},
publisher = {Frontiers Media S.A.},
month = {may},
url = {https://doi.org/10.3389%2Ffnins.2020.00335},
doi = {10.3389/fnins.2020.00335}
}
Found error?